| |
| |
|
| Insider
Information: |
Beaurang Pierre |
| Relationship: |
Chief Business Officer |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,330 |
|
|
Indirect Shares
|
116,666 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
120,996 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nurix Therapeutics, Inc. |
NRIX |
Chief Business Officer |
2021-08-10 |
4,330 |
2021-08-10 |
116,666 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-08-10 |
4 |
AS |
$29.74 |
$223,926 |
D/D |
(7,500) |
4,330 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-08-10 |
4 |
OE |
$1.11 |
$8,325 |
D/D |
7,500 |
11,830 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-07-12 |
4 |
AS |
$23.88 |
$179,419 |
D/D |
(7,500) |
4,330 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-07-12 |
4 |
OE |
$1.11 |
$8,325 |
D/D |
7,500 |
11,830 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-06-10 |
4 |
AS |
$29.15 |
$220,248 |
D/D |
(7,500) |
4,330 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-06-10 |
4 |
OE |
$1.11 |
$8,325 |
D/D |
7,500 |
11,830 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-05-10 |
4 |
AS |
$26.07 |
$198,644 |
D/D |
(7,500) |
4,330 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-05-10 |
4 |
OE |
$1.11 |
$8,325 |
D/D |
7,500 |
11,830 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-04-12 |
4 |
AS |
$26.83 |
$204,632 |
D/D |
(7,500) |
4,330 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-04-12 |
4 |
OE |
$0.84 |
$7,678 |
D/D |
7,500 |
11,830 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-03-25 |
4 |
OE |
$0.84 |
$3,637 |
D/D |
4,330 |
4,330 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-03-08 |
4 |
AS |
$36.48 |
$277,678 |
D/D |
(7,500) |
0 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-03-08 |
4 |
OE |
$0.84 |
$6,300 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-02-18 |
4 |
AS |
$34.19 |
$532,352 |
D/D |
(15,000) |
0 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-02-18 |
4 |
OE |
$0.84 |
$55,275 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
Chief Business OfficerOfficer |
• – – |
2020-07-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
116,666 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
